Chargement de la fiche…
Chargement de la fiche…
Praticien hospitalier
Dans les médias
Vous êtes Dr Olivier Vittecoq ? Présentation, expertises, actes, site du cabinet : faites de cette fiche la page de votre cabinet.
Configurer votre fiche gratuitement →Dr Olivier Vittecoq est rhumatologue à Rouen (76000). Il consulte à HOPITAL CHARLES NICOLLE CHU ROUEN, 1 Rue DE GERMONT, 76000 Rouen.
Consulter
HOPITAL CHARLES NICOLLE CHU ROUEN
1 Rue DE GERMONT, 76000 Rouen
Dr Olivier Vittecoq, c'est vous ?
Faites de cette fiche la page de votre cabinet.
Hospitalier
Pour aller plus loin
Remboursement
Pratique
Thèmes de publication
Domaines déduits des publications référencées sur PubMed.
Faits issus de registres publics et des déclarations du praticien — aucun classement.
DES Rhumatologie · Rhumatologie (SM) — Diplôme d'études spécialisées
DE Docteur en médecine — Capacité / certificat d'études spéciales
Les plus citées
2022Arthritis & rheumatology (Hoboken, N.J.)96 citations
A Risk Score to Detect Subclinical Rheumatoid Arthritis-Associated Interstitial Lung Disease
2021Annals of the rheumatic diseases91 citations
Interleukin 6 receptor inhibition in primary Sjögren syndrome: a multicentre double-blind randomised placebo-controlled trial
2024The Lancet. Rheumatology80 citations
Identification of distinct subgroups of Sjögren's disease by cluster analysis based on clinical and biological manifestations: data from the cross-sectional Paris-Saclay and the prospective ASSESS cohorts
Contenus publics où le nom du praticien apparaît (YouTube, Google Actualités).
En bref
Dr Olivier Vittecoq consulte à HOPITAL CHARLES NICOLLE CHU ROUEN, 1 Rue DE GERMONT, 76000 Rouen. Adresses issues de l'Annuaire Santé (ANS).
Par téléphone au 02 32 88 89 90 (numéro publié à l'Annuaire Santé). Un lien de recherche Doctolib est proposé sur cette page : si le praticien y est inscrit, son profil figure normalement parmi les résultats.
Identité, diplômes et lieux d'exercice : Annuaire Santé (ANS, licence ouverte). Conventionnement et carte Vitale : Assurance Maladie. Publications : bases scientifiques publiques (PubMed, HAL, OpenAlex), affichées seulement si le nom du praticien figure parmi les auteurs. Le praticien peut corriger sa fiche ou en demander le retrait à tout moment ; en cas d'homonymie, signalez-le.
Autour du cabinet
Rhumatologues à Rouen →Rhumatologues en Seine-Maritime (76) →
Vous pouvez aussi demander le retrait de la fiche.
Aperçu de votre présentation
Rhumatologue à Rouen, j'accompagne…
Exemple : vous choisissez vos propres domaines.
Anti-Carbamylated Fibrinogen Autoantibodies of IgG and IgA Isotypes Contribute to a Better Prognostic Stratification in Very Early Rheumatoid Arthritis: Data From the French National ESPOIR Cohort
2025RMD openPubMed
Joint involvement in VEXAS and non-VEXAS clonal haematopoiesis: two clusters from a multicentre regional cohort
2025Journal of multidisciplinary healthcarePubMed
The Switch from Reference Biologic Medicines to Biosimilars in France: The Perspective of Patients and Prescribers on Barriers and Needs
2024Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseasesPubMed
Lupus With Erosive Arthritis: A Singular Joint Phenotype of Lupus or Rhupus?
2021Seminars in arthritis and rheumatismPubMed
Valvular and infection-associated risk factors as criteria to guide the use of echocardiography in patients with native joint infections
2021Clinical rheumatologyPubMed
Clinical impact of a personalized pharmaceutical plan on opioid management in non-cancer pain: a pilot study
2021Frontiers in immunologyPubMed
Anti-Carbamylated Fibrinogen Antibodies Might Be Associated With a Specific Rheumatoid Phenotype and Include a Subset Recognizing In Vivo Epitopes of Its γ Chain One of Which Is Not Cross Reactive With Anti-Citrullinated Protein Antibodies
2021Journal of autoimmunityPubMed
Cardiac involvement in adult-onset Still's disease: Manifestations, treatments and outcomes in a retrospective study of 28 patients
2021Clinical rheumatologyPubMed
The impact of an in-department pharmacist on the prevention of drug iatrogenesis in a rheumatology department
2020Joint bone spinePubMed
A case of Whipple's disease mimicking auto-inflammatory disease and revealed by severe right cardiac failure under anakinra
2025Arthritis & rheumatology (Hoboken, N.J.)PubMed
Distinct Pathophysiologic Pathways Support Stratification of Sjögren's Disease Based on Symptoms, Clinical, and Routine Biological Data
2024The Lancet. RheumatologyPubMed
Treatment modalities of marginal zone lymphoma and overall survival, haematological response, and underlying Sjögren's disease activity: a multicentre, retrospective, observational study
2024The Lancet. RheumatologyPubMed
Identification of distinct subgroups of Sjögren's disease by cluster analysis based on clinical and biological manifestations: data from the cross-sectional Paris-Saclay and the prospective ASSESS cohorts
2024RMD openPubMed
Characterisation of airway disease associated with Sjögren disease
2021Joint bone spinePubMed
Epidemiology of cutaneous involvement in Sjögren syndrome: Data from three French pSS populations (TEARS, ASSESS, diapSS)
2021Annals of the rheumatic diseasesPubMed
Interleukin 6 receptor inhibition in primary Sjögren syndrome: a multicentre double-blind randomised placebo-controlled trial
2021Rheumatology (Oxford, England)PubMed
Refining myositis associated with primary Sjögren's syndrome: data from the prospective cohort ASSESS
2026BMC musculoskeletal disordersPubMed
Women with spondyloarthritis occurring in the peripartum period develop a singular phenotype
2025Joint bone spinePubMed
Evaluation by modern imaging of anterior chest wall involvement in axial spondyloarthritis with or without chest complaint
2024Joint bone spinePubMed
Determinants associated with the prescription of a first biologic therapy in patients with axial spondyloarthritis and concomitant fibromyalgia in daily practice
2024Clinical and experimental rheumatologyPubMed
Comparison of SARS-COV-2 humoral response between rheumatoid arthritis, psoriatic arthritis and spondyloarthritis patients and controls in two unvaccinated cohorts
2024Joint bone spinePubMed
A pilot study of refractory enthesitis treated with CO(2) laser in spondyloarthritis and psoriatic arthritis
2021Joint bone spinePubMed
Rheumatologic manifestations of sarcoidosis and increased risk of spondyloarthritis occurrence. A retrospective single center case-control study
2020Joint bone spinePubMed
Castleman's disease in two patients with spondyloarthritis treated by Tumor Necrosis Factor-alpha antagonists
2026Clinical immunology (Orlando, Fla.)PubMed
Autoantibody fine specificity restriction is associated with clinical response in RA treated with abatacept and methotrexate
2025Clinical and experimental rheumatologyPubMed
Macrophage requirements for abatacept response in rheumatoid arthritis
2024Rheumatology (Oxford, England)PubMed
Can efficacy and safety data from clinical trials of rituximab in RA be extrapolated? Insights from 1984 patients from the AIR-PR Registry
2023Clinical and experimental rheumatologyPubMed
Clinical and ultrasonographic evaluation of the window of opportunity for retreatment with rituximab in rheumatoid arthritis patients from a multicentre real-life study
2022Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseasesPubMed
Potential Benefit of Rituximab in Rhupus Patients From a Single-Center: A Series of 16 Cases
2020PloS onePubMed
Gene expression regulated by abatacept associated with methotrexate and correlation with disease activity in rheumatoid arthritis
2026Clinical immunology (Orlando, Fla.)PubMed
Autoantibody fine specificity restriction is associated with clinical response in RA treated with abatacept and methotrexate
2025The Lancet. RheumatologyPubMed
Effect of a 1-month methotrexate delay on pneumococcal vaccine immunogenicity and disease control in patients with early rheumatoid arthritis (VACIMRA): an open-label randomised trial
2022Arthritis research & therapyPubMed
Validation in the ESPOIR cohort of vitamin K-dependent protein S (PROS) as a potential biomarker capable of predicting response to the methotrexate/etanercept combination
2020PloS onePubMed
Gene expression regulated by abatacept associated with methotrexate and correlation with disease activity in rheumatoid arthritis
2025Clinical and experimental rheumatologyPubMed
Evaluation of the nocebo effect after switching from etanercept or adalimumab originator to a biosimilar: a retrospective study of patients with inflammatory rheumatism
2022Arthritis research & therapyPubMed
Validation in the ESPOIR cohort of vitamin K-dependent protein S (PROS) as a potential biomarker capable of predicting response to the methotrexate/etanercept combination
2024Clinical and experimental rheumatologyPubMed
Association between treatment type and therapeutic response according to clinical form of SAPHO syndrome in adults from a multicentre retrospective cohort study
2021European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical MicrobiologyPubMed
Microbiological diagnosis of suspected vertebral osteomyelitis with a focus on the yield of percutaneous needle biopsy: a 10-year cohort study
2024Clinical and experimental rheumatologyPubMed
Comparison of SARS-COV-2 humoral response between rheumatoid arthritis, psoriatic arthritis and spondyloarthritis patients and controls in two unvaccinated cohorts
2024Joint bone spinePubMed
A pilot study of refractory enthesitis treated with CO(2) laser in spondyloarthritis and psoriatic arthritis
2026 · Article
Women with spondyloarthritis occurring in the peripartum period develop a singular phenotype
2026 · Article
Autoantibody fine specificity restriction is associated with clinical response in RA treated with abatacept and methotrexate
2025 · Article
Modalités d’emploi, tolérance et efficacité de la colchicine pour le traitement d’accès aigus microcristallins chez des patients insuffisants rénaux sévères
2025 · Article
The Switch from Reference Biologic Medicines to Biosimilars in France: The Perspective of Patients and Prescribers on Barriers and Needs
2025 · Article
Joint involvement in VEXAS and non-VEXAS clonal haematopoiesis: two clusters from a multicentre regional cohort
2025 · Article
Evaluation by modern imaging of anterior chest wall involvement in axial spondyloarthritis with or without chest complaint
2025 · Article
Could the anti-modified protein antibody concept help better define seronegative rheumatoid arthritis?
2025 · Article
Effect of a 1-month methotrexate delay on pneumococcal vaccine immunogenicity and disease control in patients with early rheumatoid arthritis (VACIMRA): an open-label randomised trial
Publications affichées uniquement lorsque le nom du praticien figure parmi les auteurs. Une erreur d'homonymie ? Signalez-la depuis le lien en bas de page.
2025 · doctorant : Pauline Brevet
La répοnse anti-fibrinοgène carbamylé dans la pοlyarthrite rhumatοide : identificatiοn des cibles antigéniques et significatiοn clinique
2015 · doctorant : Clément Guillou
Étude des effets de l'alpha-énolase sur les cellules mononucléées du sang périphérique de sujets sains et de patients atteints de polyarthrite rhumatoïde, et dans le modèle murin d'arthrite induite au collagène
2013 · doctorant : Antoine Obry
Identification par des approches protéomiques innovantes de biomarqueurs sériques prédictifs de la réponse à l'association méthotrexate/etanercept dans la polyarthrite rhumatoïde
2008 · doctorant : Vincent Goëb
Identification de marqueurs diagnostiques de la polyarthrite rhumatoïde par une double approche génétique et protéomique